Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients.Marianna Nuti, Paolo Marchetti, Ilaria Grazia Zizzari et al.|Journal of Clinical Oncology|2017Cited by 5
Oncological patients' reactions to <scp>COVID</scp>‐19 pandemic: A single institution prospective studyConcetta Elisa Onesti, Guy Jérusalem, Aurélie Poncin et al.|Cancer Reports|2021Cited by 2
How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in BelgiumConcetta Elisa Onesti, Guy Jérusalem, Hélène Schroeder et al.|Open Repository and Bibliography (University of Liège)|2020Cited by 0